BM Reconstitution Potential of Ex Vivo–Manipulated CD34++CD38−Lin− Fetal Liver Cells
Experiment No. . | Weeks . | Cytokine* . | Injected Cells† . | Reconstitution (%)‡ . | |||
---|---|---|---|---|---|---|---|
. | . | . | . | Total . | CD19+ . | CD33+ . | CD34+ . |
1 | 4 | C1 | 8,400 | 54 | 27 | 78 | 60 |
C1 | 8,400 | 55 | 33 | 65 | 64 | ||
C2 | 6,400 | 26 | 9 | 53 | 38 | ||
C2 | 6,400 | 29 | 9 | 57 | 33 | ||
C2 | 6,400 | 47 | 25 | 61 | 50 | ||
2 | 4 | C2 | 13,800 | 48 | 36 | 56 | 53 |
C1 | 13,800 | 35 | 10 | ND | ND | ||
7 | C2 | 13,800 | 100 | 89 | 71 | 73 | |
3 | 4 | C1 | 7,500 | 43 | 24 | 71 | 58 |
C2 | 5,000 | 29 | 17 | 47 | 13 | ||
C2 | 5,000 | 50 | 57 | 65 | 54 | ||
4 | 8 | C1 | 5,400 | 66 | 65 | 66 | 71 |
C1 | 5,400 | 26 | 18 | 56 | 39 | ||
C1 | 600 | 42 | 22 | 38 | 23 | ||
C1 | 600 | 75 | 79 | 50 | 65 | ||
C2 | 5,400 | 77 | 59 | 83 | ND | ||
5 | 8 | C1 | 7,200 | 75 | 65 | 82 | 65 |
C1 | 7,200 | 93 | 90 | 93 | 91 | ||
C1 | 1,500 | 94 | 96 | 90 | 86 | ||
C1 | 1,500 | 10 | 4 | 37 | 21 | ||
C1 | 750 | 98 | 98 | 96 | 91 | ||
C1 | 750 | 91 | 99 | 98 | 95 | ||
C2 | 7,200 | 98 | 97 | 99 | 99 | ||
C2 | 7,200 | 91 | 86 | 97 | 96 | ||
C2 | 1,500 | 87 | 86 | 87 | 88 | ||
C2 | 750 | 86 | 73 | 97 | 98 | ||
6 | 8 | C2 | 24,000 | 98 | 99 | 97 | 95 |
C3 | 2,700 | 94 | 95 | 94 | 96 | ||
C3 | 24,000 | 97 | 98 | 97 | 95 | ||
7 | 9 | C2 | 17,600 | 92 | 65 | 92 | 65 |
C2 | 2,000 | 74 | 90 | 93 | 91 | ||
C3 | 17,600 | 51 | 40 | 27 | 31 | ||
8 | 10 | C1 | 4,500 | 90 | ND | ND | ND |
C1 | 500 | 74 | ND | ND | ND | ||
C2 | 4,500 | 100 | ND | ND | ND | ||
C2 | 500 | 89 | ND | ND | ND | ||
9 | 11 | C2 | 6,300 | 76 | ND | ND | ND |
11 | 14 | C2 | 10,600 | 96 | 99 | 92 | 95 |
12 | 17 | C2 | 4,300 | 99 | 99 | ND | ND |
C2 | 4,300 | 97 | 98 | ND | ND | ||
C3 | 13,100 | 95 | 96 | 95 | 91 | ||
C3 | 4,300 | 95 | 97 | ND | ND |
Experiment No. . | Weeks . | Cytokine* . | Injected Cells† . | Reconstitution (%)‡ . | |||
---|---|---|---|---|---|---|---|
. | . | . | . | Total . | CD19+ . | CD33+ . | CD34+ . |
1 | 4 | C1 | 8,400 | 54 | 27 | 78 | 60 |
C1 | 8,400 | 55 | 33 | 65 | 64 | ||
C2 | 6,400 | 26 | 9 | 53 | 38 | ||
C2 | 6,400 | 29 | 9 | 57 | 33 | ||
C2 | 6,400 | 47 | 25 | 61 | 50 | ||
2 | 4 | C2 | 13,800 | 48 | 36 | 56 | 53 |
C1 | 13,800 | 35 | 10 | ND | ND | ||
7 | C2 | 13,800 | 100 | 89 | 71 | 73 | |
3 | 4 | C1 | 7,500 | 43 | 24 | 71 | 58 |
C2 | 5,000 | 29 | 17 | 47 | 13 | ||
C2 | 5,000 | 50 | 57 | 65 | 54 | ||
4 | 8 | C1 | 5,400 | 66 | 65 | 66 | 71 |
C1 | 5,400 | 26 | 18 | 56 | 39 | ||
C1 | 600 | 42 | 22 | 38 | 23 | ||
C1 | 600 | 75 | 79 | 50 | 65 | ||
C2 | 5,400 | 77 | 59 | 83 | ND | ||
5 | 8 | C1 | 7,200 | 75 | 65 | 82 | 65 |
C1 | 7,200 | 93 | 90 | 93 | 91 | ||
C1 | 1,500 | 94 | 96 | 90 | 86 | ||
C1 | 1,500 | 10 | 4 | 37 | 21 | ||
C1 | 750 | 98 | 98 | 96 | 91 | ||
C1 | 750 | 91 | 99 | 98 | 95 | ||
C2 | 7,200 | 98 | 97 | 99 | 99 | ||
C2 | 7,200 | 91 | 86 | 97 | 96 | ||
C2 | 1,500 | 87 | 86 | 87 | 88 | ||
C2 | 750 | 86 | 73 | 97 | 98 | ||
6 | 8 | C2 | 24,000 | 98 | 99 | 97 | 95 |
C3 | 2,700 | 94 | 95 | 94 | 96 | ||
C3 | 24,000 | 97 | 98 | 97 | 95 | ||
7 | 9 | C2 | 17,600 | 92 | 65 | 92 | 65 |
C2 | 2,000 | 74 | 90 | 93 | 91 | ||
C3 | 17,600 | 51 | 40 | 27 | 31 | ||
8 | 10 | C1 | 4,500 | 90 | ND | ND | ND |
C1 | 500 | 74 | ND | ND | ND | ||
C2 | 4,500 | 100 | ND | ND | ND | ||
C2 | 500 | 89 | ND | ND | ND | ||
9 | 11 | C2 | 6,300 | 76 | ND | ND | ND |
11 | 14 | C2 | 10,600 | 96 | 99 | 92 | 95 |
12 | 17 | C2 | 4,300 | 99 | 99 | ND | ND |
C2 | 4,300 | 97 | 98 | ND | ND | ||
C3 | 13,100 | 95 | 96 | 95 | 91 | ||
C3 | 4,300 | 95 | 97 | ND | ND |
Results of 42 BM samples that were reconstituted by injected fetal liver cells are shown.
Abbreviation: ND, not determined.
C1: IL-3 + IL-6 + GM-CSF + KL; C2: IL-3 + IL-6 + GM-CSF + KL + FL; C3: IL-6 + KL + FL.
Number of injected cells are indicated as the number of CD34++CD38−Lin− cells at the initiation of culture.
Contribution of fetal liver–derived cells was assessed based on the HLA alloantigen expression.